Investors on the quest for market-beating returns often employ the strategy of stock picking. Making informed choices in stocks can greatly amplify your wealth.
The price of Annovis Bio Inc (NYSE: ANVS) closed at $1.61 in the last session, up 2.55% from day before closing price of $1.57. In other words, the price has increased by $2.55 from its previous closing price. On the day, 0.68 million shares were traded. ANVS stock price reached its highest trading level at $1.75 during the session, while it also had its lowest trading level at $1.57.
Ratios:
We take a closer look at ANVS’s different ratios to gain a better understanding of the stock. For the most recent quarter (mrq), Quick Ratio is recorded 3.59 and its Current Ratio is at 3.59. In the meantime, Its Debt-to-Equity ratio is 0.00 whereas as Long-Term Debt/Eq ratio is at 0.00.
On October 25, 2024, Maxim Group Upgraded its rating to Buy which previously was Hold but kept the price unchanged to $25.
On December 29, 2023, Canaccord Genuity started tracking the stock assigning a Buy rating and target price of $36.Canaccord Genuity initiated its Buy rating on December 29, 2023, with a $36 target price.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, ANVS now has a Market Capitalization of 31372782 and an Enterprise Value of 20820916.
Stock Price History:
The Beta on a monthly basis for ANVS is 1.44, which has changed by -0.7012987 over the last 52 weeks, in comparison to a change of 0.09765589 over the same period for the S&P500. Over the past 52 weeks, ANVS has reached a high of $17.88, while it has fallen to a 52-week low of $1.11. The 50-Day Moving Average of the stock is 0.59%, while the 200-Day Moving Average is calculated to be -72.06%.
Shares Statistics:
According to the various share statistics, ANVS traded on average about 502.41K shares per day over the past 3-months and 732480 shares per day over the past 10 days. A total of 19.49M shares are outstanding, with a floating share count of 16.67M. Insiders hold about 14.45% of the company’s shares, while institutions hold 13.22% stake in the company. Shares short for ANVS as of 1744675200 were 1744449 with a Short Ratio of 3.47, compared to 1741910400 on 1879232. Therefore, it implies a Short% of Shares Outstanding of 1744449 and a Short% of Float of 10.459999999999999.
Dividends & Splits
Against a Trailing Annual Dividend Yield of 0.0
Earnings Estimates
The dynamic stock of Annovis Bio Inc (ANVS) is currently attracting attention from 1 analysts actively involved in rating its market status.The consensus estimate for the next quarter is -$0.32, with high estimates of -$0.32 and low estimates of -$0.32.
Analysts are recommending an EPS of between -$0.78 and -$0.78 for the fiscal current year, implying an average EPS of -$0.78. EPS for the following year is -$0.3, with 1.0 analysts recommending between -$0.3 and -$0.3.
